Fig. 5From: Clinical significance of cyclin-dependent kinase inhibitor 2C expression in cancers: from small cell lung carcinoma to pan-cancersThe expression of CDKN2C and its mutation landscape in pan-cancer. Panel A: The expression of CDKN2C mRNA expression in pan-cancer tissues. *p < 0.05; nsp ≥ 0.05. Panel B: The expression of CDKN2C mRNA expression in cancer cell lines. Panel C: The landscape of CDKN2C’s mutations in pan-cancerBack to article page